Wako, Japan

Akiko Kumagai



Average Co-Inventor Count = 2.9

ph-index = 1


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Akiko Kumagai: Innovator in Bilirubin Measurement Technologies

Introduction

Akiko Kumagai is a prominent inventor based in Wako, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the measurement of bilirubin levels in blood samples. With a total of 2 patents, her work has the potential to enhance the accuracy of bilirubin detection, which is crucial for diagnosing various health conditions.

Latest Patents

Kumagai's latest patents include a measurement method for unbound bilirubin in blood samples. This innovative method allows for the precise reflection of unbound bilirubin levels, regardless of the presence of conjugated bilirubin. The process involves several steps: an oxidative decomposition reaction, a stopping step, a contact step with a specific binding agent, and a detection step that measures fluorescence to derive the amount of unbound bilirubin.

Another notable patent is a method for detecting bilirubin using a novel fluorescent protein. This polypeptide exhibits fluorescent properties in the presence of bilirubin and includes specific amino acid sequences that enhance its functionality. This advancement could lead to more effective diagnostic tools in clinical settings.

Career Highlights

Throughout her career, Akiko Kumagai has worked with esteemed institutions such as Kobe University and RIKEN Corporation. Her research has focused on developing innovative methods for bilirubin detection, contributing to advancements in medical diagnostics.

Collaborations

Kumagai has collaborated with notable colleagues, including Atsushi Miyawaki and Sota Iwatani. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medical research.

Conclusion

Akiko Kumagai's contributions to the field of bilirubin measurement are noteworthy and have the potential to significantly impact medical diagnostics. Her innovative patents and collaborations highlight her dedication to advancing healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…